1-1 of 1
Davide Dalu, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

TARC Is Useful as Additional Prognostic Factor for Hodgkin's Lymphoma Outcome.

Simonetta Viviani, MD, Arabella Mazzocchi, Valeria Bonfante, Rosalba Miceli, MD, Davide Dalu, MD, Marina Galbiati, Fernando Ravagnani, Luigi Mariani, Alessandro Massimo Gianni
Journal: Blood
Blood (2009) 114 (22): 1557.
https://doi.org/10.1182/blood.V114.22.1557.1557
Published: 2009